Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 118214
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118214
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118214
Table 1 Risk of bias assessment of included studies using the risk of bias in non-randomised studies - of interventions tool
| Ref. | Vaccine | Confounding | Selection of participants | Exposure classification | Deviations from intended interventions | Missing data | Outcome measurement | Selection of reported results | Overall risk of bias |
| Kamei et al[10], 2023 | COVID-19 | Serious | Moderate | Low | Moderate | Low | Low | Moderate | Serious |
| Waldman et al[11], 2023 | COVID-19 | Serious | Serious | Low | Low | Moderate | Low | Moderate | Serious |
| Sanders et al[12], 2022 | COVID-19 | Serious | Moderate | Low | Low | Moderate | Low | Moderate | Serious |
| Wan et al[13], 2022, | COVID-19 | Low | Moderate | Low | Low | Moderate | Moderate | Low | Moderate |
| Yechezkel et al[14], 2023 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Moderate | Low | Moderate |
| Choi et al[15], 2024 | COVID-19 | Moderate | Low | Low | Low | Low | Serious | Moderate | Moderate |
| Lionaki et al[16], 2024 | COVID-19 | Moderate | Moderate | Low | Low | Low | Moderate | Low | Moderate |
| Poster Abstracts[17], 2022 | COVID-19 | Serious | Moderate | Low | Low | Moderate | Low | Moderate | Serious |
| Carrillo et al[18], 2023 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Low | Moderate | Moderate |
| Chen et al[19], 2023 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Low | Moderate | Moderate |
| Diebold et al[20], 2022 | COVID-19 | Low | Low | Low | Low | Low | Low | Low | Low |
| Canney et al[21], 2022 | COVID-19 | Low | Low | Low | Low | Low | Low | Low | Low |
| Ota et al[22], 2023 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Low | Moderate | Moderate |
| Wang et al[23], 2024 | COVID-19 | Low | Low | Low | Low | Low | Low | Low | Low |
| Sun et al[24], 2024 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Low | Moderate | Moderate |
| Nagatsuji et al[25], 2024 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Low | Moderate | Moderate |
| Aoki et al[26], 2024 | COVID-19 | Serious | Serious | Low | Low | Moderate | Low | Moderate | Serious |
| Zhang et al[27], 2024 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Low | Low | Moderate |
| Mazza et al[28], 2025 | COVID-19 | Moderate | Moderate | Low | Low | Low | Low | Low | Moderate |
| Thepveera et al[29], 2025 | COVID-19 | Moderate | Moderate | Low | Low | Moderate | Low | Moderate | Moderate |
| Tsai et al[30], 2025 | COVID-19 | Moderate | Low | Low | Low | Low | Moderate | Low | Moderate |
| Huang et al[31], 2025 | COVID-19 | Moderate | Low | Low | Low | Low | Moderate | Low | Moderate |
| Ishimori et al[32], 2023 | Influenza | Moderate | Moderate | Low | Low | Low | Low | Low | Moderate |
| Hao et al[33], 2023 | Influenza | Moderate | Low | Low | Low | Moderate | Moderate | Moderate | Moderate |
| Moghaddasi et al[34], 2013 | Influenza | Serious | Serious | Low | Low | Moderate | Low | Moderate | Serious |
| Fernández-Ruiz et al[35], 2015 | Influenza | Serious | Moderate | Low | Low | Moderate | Low | Moderate | Serious |
| Cohet et al[36], 2016 | Influenza | Low | Low | Low | Low | Low | Moderate | Low | Low |
| Dos Santos et al[37], 2016 | Influenza | Low | Low | Low | Low | Moderate | Low | Low | Low |
| Miskulin et al[38], 2018 | Influenza | Moderate | Low | Low | Low | Moderate | Low | Moderate | Moderate |
| Klifa et al[39], 2019 | Influenza | Serious | Serious | Moderate | Low | Moderate | Moderate | Moderate | Serious |
| Ishimori et al[40], 2021 | Influenza | Moderate | Moderate | Low | Low | Moderate | Moderate | Low | Moderate |
| Kumar et al[41], 2023 | Influenza | Moderate | Moderate | Low | Low | Moderate | Low | Low | Moderate |
| Levison et al[42], 2022 | Influenza | Low | Low | Low | Low | Low | Low | Low | Low |
| Shih et al[43], 2018 | Influenza | Moderate | Low | Low | Low | Low | Low | Low | Moderate |
| Cho et al[44], 2024 | Influenza | Low | Low | Low | Low | Low | Low | Low | Low |
| Zhuo et al[45], 2026 | Influenza | Moderate | Low | Low | Low | Low | Moderate | Low | Moderate |
| Chen et al[46], 2025 | Influenza | Moderate | Low | Low | Low | Low | Moderate | Low | Moderate |
| Liao et al[47], 2022 | Influenza | Moderate | Low | Low | Low | Low | Low | Low | Moderate |
| Sheth et al[48], 1979 | Influenza | Serious | Serious | Low | Moderate | Moderate | Moderate | Moderate | Serious |
| Jeffs et al[49], 2015 | Influenza | Low | Low | Low | Moderate | Low | Low | Low | Low |
| Chen et al[50], 2022 | Influenza | Moderate | Low | Low | Low | Low | Moderate | Low | Moderate |
| Pabico et al[51], 1974 | Influenza | Serious | Moderate | Low | Moderate | Low | Low | Moderate | Serious |
| Reynales et al[52], 2012 | Influenza | Serious | Moderate | Low | Low | Low | Moderate | Low | Serious |
| Gwynn et al[53], 2020 | Influenza | Serious | Moderate | Low | Moderate | Low | Moderate | Moderate | Serious |
| Ishimori et al[54], 2020 | Influenza | Moderate | Moderate | Low | Moderate | Low | Low | Low | Moderate |
| Zawiasa-Bryszewska et al[55], 2025 | Influenza | Moderate | Moderate | Low | Moderate | Moderate | Moderate | Low | Moderate |
- Citation: Aye Kyaw YH, Yip P, See KC. Post vaccination acute kidney injury and other renal complications after COVID-19 and influenza vaccination. World J Nephrol 2026; 15(2): 118214
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/118214.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.118214